Working together with clients, we design studies and utilize approaches and tools that unequivocally guarantee the most scientifically accurate data. NeuroCog supports all stages of clinical trials from design through study implementation and interpretation of results. Below are links to some of the data we have presented based on our approach.

Development and Validation of the Tablet-based Brief Assessment of Cognition (BAC App) for Schizophrenia

Posted

This poster was presented at the International Congress on Schizophrenia Research in San Diego 24-28 March 2017. The Brief Assessment of Cognition in Schizophrenia (BACS) is a pen-and-paper cognitive assessment tool that has been used in hundreds of research studies and clinical trials, and has … Continued

Tagged: , , , , ,

Assessing Functional Capacity using the UCSD Performance-based Skills Assessment (UPSA-2-VIM) and the Virtual Reality Functional Capacity Assessment Tool (VRFCAT)

Posted

This poster was presented at the Annual Meeting of the American Society for Experimental NeuroTherapeutics (ASENT)  15-17 March 2017 Washington DC/Rockville MD Reliable measurement of functional capacity is critical in assessing the efficacy of treatments for cognitive impairment in a wide range of CNS disorders … Continued

Estimating Treatment Effect Heterogeneity in Cognitive Training Programs

Posted

Cognitive functioning deficits within the schizophrenia population are heterogeneous. Specifically, these deficits vary between subjects, for example in terms of disease etiology, age, sex, and level of psychopathology, concomitant medications (e.g., time medications were given prior to testing), metabolic functioning (e.g., glucose levels at the … Continued

Tagged: , , ,
Page 1 Page 2 Page 3 Page 11